These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12709796)

  • 21. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
    Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications among premature neonates treated with beractant and poractant alfa.
    Gharehbaghi MM; Sakha SH; Ghojazadeh M; Firoozi F
    Indian J Pediatr; 2010 Jul; 77(7):751-4. PubMed ID: 20589459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of surfactant preparations in premature infants.
    Trembath A; Hornik CP; Clark R; Smith PB; Daniels J; Laughon M;
    J Pediatr; 2013 Oct; 163(4):955-60.e1. PubMed ID: 23769501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
    Ramanathan R
    J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group.
    Valls-i-Soler A; Fernández-Ruanova B; López-Heredia y Goya J; Román Etxebarría L; Rodriguez-Soriano J; Carretero V
    Pediatrics; 1998 Apr; 101(4):E4. PubMed ID: 9533371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome.
    Lam BC; Ng YK; Wong KY
    Pediatr Pulmonol; 2005 Jan; 39(1):64-9. PubMed ID: 15558604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Three Different Administration Positions for Intratracheal Beractant in Preterm Newborns with Respiratory Distress Syndrome.
    Karadag A; Ozdemir R; Degirmencioglu H; Uras N; Dilmen U; Bilgili G; Erdeve O; Cakir U; Atasay B
    Pediatr Neonatol; 2016 Apr; 57(2):105-12. PubMed ID: 26190853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV; Dooley M; Goa KL
    Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of natural surfactant on mortality and morbidity in neonates with a birth weight below 1500 grams].
    Stranák Z; Janota J; Miletín J; Simák J
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():38-42. PubMed ID: 11394231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In response to mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Egan EA
    J Perinatol; 2013 Feb; 33(2):165-6. PubMed ID: 23361501
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome.
    Yalaz M; Arslanoglu S; Akisu M; Atik T; Ergun O; Kultursay N
    Klin Padiatr; 2004; 216(4):230-5. PubMed ID: 15284947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the outcomes of neonates treated with two different natural surfactants.
    Clark RH; Auten RL; Peabody J
    J Pediatr; 2001 Dec; 139(6):828-31. PubMed ID: 11743508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous surfactant use in neonates.
    Ishisaka DY
    Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
    Dunn MS; Shennan AT; Zayack D; Possmayer F
    Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.